Dach Daily™

Home NewsDACHHealthcare Switzerland: Novocure secures non-dilutive funding from Pharmakon

Switzerland: Novocure secures non-dilutive funding from Pharmakon

by admin


Nasdaq-listed, Root-headquartered global oncology company, Novocure, has entered into a new five-year senior secured credit facility of up to US$400m with funds managed by Pharmakon Advisors. The committed capital will be available to Novocure in four tranches of US$100m.

Pharmakon Advisors is an investor in non-dilutive debt for the life sciences industry and is the investment manager of the BioPharma Credit funds.

The first US$100m has already been issued, with the second US$100m tranche to be issued by June 30, 2025. An…



Source link

You may also like

About Us

Dach Daily™ aggregates, publishes and distributes news to media in the DACH region (Germany (D), Austria (A) and Switzerland (CH). Dach Daily™, in association with EuropeNewswire.net™, not only provides press release distribution to news outlets in the DACH region, but the newswire service also reaches media in the entire Europe.

Recent News

Dach Daily™ is part of GroupWeb Media Network. © 2024 GroupWeb Media LLC